Altre lingue Corline Biomedical AB

Azioni

CLBIO

SE0006887451

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 16:54:11 16/05/2024			Variaz. 5gg	Var. 1 gen.
10,1 ^SEK	0,00%		+0,50%	-32,21%

30/04	Corline Biomedical AB riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
14/02	Corline Biomedical AB riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023	14/02
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	14/02
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11
Corline Biomedical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	24/02/23
Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2022	24/02/23
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	25/11/22
Corline Biomedical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	25/08/22
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	23/02/22
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	25/11/21
Corline Biomedical AB Reports Earnings Results for the Second Quarter Ended June 30, 2021	25/08/21
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2021	10/05/21
Corline Biomedical AB announced that it has received SEK 35.475 million in funding from M2 Asset Management AB, HealthInvest Partners AB, and other investors	30/03/21
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	26/02/21
Corline Biomedical AB to Enter into Agreement with the Clinical Islet Transplant Program at University of Alberta	05/07/17
Corline Biomedical AB to Enter into Agreement with Nuffield Department of Surgical Sciences	30/06/17
Corline Biomedical AB has completed an IPO in the amount of SEK 12.04 million.	28/04/15

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Corline Biomedical AB

Azioni

CLBIO

SE0006887451

Altre lingue

Filtri